Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Information
- Disease name
- Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04799275 | Recruiting | Phase 2/Phase 3 | Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma | May 20, 2021 | March 1, 2026 |
| NCT05202782 | Recruiting | Phase 2 | Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma | March 21, 2022 | October 9, 2029 |